The Insurance Council of British Columbia (the Council) has imposed conditions on former life and accident and sickness ...
New research found a simplified clot-preventing medication regimen following stent placement in adults with atrial ...
Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the ...
KELOLAND.com on MSN
Sanford cardiac rehab program moves across town
Sanford Health’s cardiac rehabilitation program in Sioux Falls has moved. Larry Gruseth, 79, has been using the program since ...
She is now under 24-hour intensive observation. Urgent tests have been completed and she has been given antibiotics and emergency treatment,” he added ...
Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.
WWE Hall of Famer Kevin Nash explains why he now thinks that he had a "minor heart attack" 20 years ago following a recent ...
Peytant Solutions CEO John Schorgl explains how his device startup turned a complex FDA de novo application into a lasting ...
News-Medical.Net on MSN
Prasugrel shows advantage over ticagrelor in diabetic patients after stent placement
One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors-ticagrelor or prasugrel-in people with Type 1 ...
News-Medical.Net on MSN
One-month dual therapy strategy offers advantages for AFib patients and clinicians
New research found a simplified clot-preventing medication regimen following stent placement in adults with atrial ...
Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...
Medical Device Network on MSN
Gore’s venous stent study meets primary endpoint
W. L. Gore & Associates’ medical division has reported that a study of the GORE VIABAHN FORTEGRA Venous Stent met its primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback